Indian benchmark indices extended their losing streak for a fourth consecutive session on Thursday. Nifty 50 fell 0.17% and Sensex declined...

The latest GDP metrics reveal a robust real growth of 7.8% for Q1 FY27, although some dissent surfaced due to erroneous comparisons between...

Fosun Pharma plans to divest 5% equity in Gland Pharma through a Rs 2,279.5 crore block deal at Rs 2,763 per share. Gland Pharma reported a...

Persistent Systems approved plans to raise up to $1.25 billion through debt and up to $450 million via equity-linked instruments, subject t...

India's statistics ministry defended its latest GDP growth figures. The ministry cited improved data sources and methodologies for the esti...

Monsoon illnesses and a significant rise in H1N1 cases are driving a surge in demand for acute therapies and flu vaccines. Sales of anti-in...

The BSE Sensex ended at 76,944.28, lower by 12.99 points or 0.02%, as gains in IT, FMCG and select heavyweights helped limit the fall.

Indian midcap and smallcap indices are near record highs currently. A few select stocks are driving most of these significant gains. This c...

Ace investor Ashish Dhawan bought nearly 35 lakh shares of Religare Enterprises across two sessions, according to NSE bulk deal data, sendi...

Milky Mist Dairy Food shares rallied over 9% after the dairy products maker reported a nearly tenfold year-on-year jump in Q1 profit to Rs ...

Indian equity markets ended lower on August 31, responding to prevailing global economic dynamics. A modest decline in the Nifty50 index br...

Blackstone-backed Epsilon Bidco plans to sell its 26.4% stake in packaging firm EPL Ltd through a block deal valued at approximately Rs 1,9...

India’s GDP grew 7.8% in Q1 FY27, slower than the revised 8.6% in Q4 FY26, but faster than the revised 6.9% in Q1 FY26. The Q1 growth beat ...

India's real GDP grew 7.8 percent in the April-June quarter. This performance exceeded the Reserve Bank of India's earlier growth forecast....

Nomura initiated coverage on Clean Max Enviro Energy Solutions with a Buy rating and a Rs 1,510 target, implying 21% upside, citing strong ...

Marksans Pharma shares surged after Q1FY27 profit jumped 174% YoY to Rs 159 crore. Revenue rose 35.6% to Rs 841 crore, while EBITDA hit a r...

Gland Pharma shares rose sharply after Q1FY27 profit rose 47% and revenue grew 20% year-on-year. While strong margins and CDMO growth promp...